IL15 and cancer: However, the degree to which activating ligands expressed by cancer cells versus additional signals (e.g., from cytokines such as type I IFNs or IL-15) (Delconte et al., 2016) contribute to NK cell-dependent ignition of anti-cancer immunity remains to be elucidated.